{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:13:24Z","timestamp":1776942804348,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Poverty"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Loiasis affects more than 20 million residents of endemic regions in Central and West Africa causing chronic and often lifelong disease. Antifilarial treatment options for loiasis include diethylcarbamazine, ivermectin, and albendazole. Safe and effective management requires classifying patients into occult, microfilaremia, and hypermicrofilaremia categories. Treatment is complicated by the risk of severe adverse events, particularly encephalitis. Clear guidance on the appropriate use of antifilarial therapy is therefore of utmost importance. The aim of this review is to evaluate current treatment recommendations and assess their quality and consistency.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A scoping review was conducted to evaluate treatment recommendations for loiasis. The literature search encompassed multiple databases, including PubMed and specialized medical repositories, without restrictions on publication date or language. The approach included a systematic search with specific loiasis-related keywords and an unstructured search of guidelines from health ministries in endemic countries, along with grey literature and professional recommendations. Renowned tropical medicine textbooks were also consulted. Data were extracted with a detailed table collaboratively developed and reviewed by multiple researchers to ensure consistency and accuracy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The review identified 33 sources, consisting of nine guidelines, ten reviews, and 14 textbook excerpts. Publications reviewed spanned from 2001 to 2024 with no major innovations in treatment noted. Evidence quality was often low, with only two guidelines detailing their development process. Variability was particularly noted in dosage protocols for diethylcarbamazine, typically dosed incrementally. Ivermectin and albendazole were mostly noted as alternatives based on microfilarial levels. The common microfilarial threshold was 8000 microfilariae per millilitre, dictating treatment strategy adjustments. Adjunctive treatments, such as corticosteroids and antihistamines, were inconsistently proposed to mitigate side effects.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Inconsistencies between some recommendations were observed. There is an urgent need for internationally harmonized, evidence-based guidelines to address these inconsistencies, improve patient outcomes and minimize treatment-associated severe adverse events and fatalities.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s40249-025-01300-0","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T03:44:15Z","timestamp":1746589455000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Treatment of loiasis: a review of clinical management recommendations"],"prefix":"10.1186","volume":"14","author":[{"given":"Dorothea","family":"Ekoka Mbassi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rike","family":"Dree\u00dfen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rella","family":"Zoleko Manego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia Dede","family":"Davi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Nordmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Mischlinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9259-1885","authenticated-orcid":false,"given":"Michael","family":"Ramharter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"issue":"3","key":"1300_CR1","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.1016\/S1473-3099(23)00438-3","volume":"24","author":"M Ramharter","year":"2024","unstructured":"Ramharter M, Butler J, Mombo-Ngoma G, Nordmann T, Davi SD, Zoleko MR. The African eye worm: current understanding of the epidemiology, clinical disease, and treatment of loiasis. Lancet Infect Dis. 2024;24(3):e165\u201378.","journal-title":"Lancet Infect Dis"},{"key":"1300_CR2","first-page":"43","volume-title":"Loa loa: latest advances in Loiasis research","author":"A Klion","year":"2024","unstructured":"Klion A. Clinical aspects: treatment of simple and complicated forms of loiasis of chapter. In: Akue JP, editor. Loa loa: latest advances in Loiasis research. 1st ed. Cham: Springer; 2024. p. 43\u20139.","edition":"1"},{"key":"1300_CR3","doi-asserted-by":"publisher","first-page":"100582","DOI":"10.1016\/j.eclinm.2020.100582","volume":"28","author":"CB Chesnais","year":"2020","unstructured":"Chesnais CB, Pion SD, Boulle C, Gardon J, Gardon-Wendel N, Fokom-Domgue J, et al. Individual risk of post-ivermectin serious adverse events in subjects infected with Loa loa. EClinicalMedicine. 2020;28:100582.","journal-title":"EClinicalMedicine"},{"key":"1300_CR4","unstructured":"World Health Organization. Diethylcarbamazine Citrate 100mg tablets, (Eisai Co, Ltd), NT002. In: World Health Organization (eds.) WHO Public Assessment Reports, volume 4. 2016; Geneva: World Health Organization."},{"issue":"10","key":"1300_CR5","doi-asserted-by":"publisher","first-page":"e299","DOI":"10.1016\/S1473-3099(22)00064-0","volume":"22","author":"KH Jacobsen","year":"2022","unstructured":"Jacobsen KH, Andress BC, Bhagwat EA, Bryant CA, Chandrapu VR, Desmonts CG, et al. A call for loiasis to be added to the WHO list of neglected tropical diseases. Lancet Infect Dis. 2022;22(10):e299\u2013302.","journal-title":"Lancet Infect Dis"},{"key":"1300_CR6","unstructured":"Direction g\u00e9n\u00e9rale de la sant\u00e9: Directives du traitement de la loase. Edited by Programme de lutte contre les maladies parasitaires. Libreville: Minist\u00e8re de la sant\u00e9 de la r\u00e9publique gabonaise; unknown year (in French)."},{"key":"1300_CR7","unstructured":"Deutsche Gesellschaft f\u00fcr Tropenmedizin Reisemedizin und Globale Gesundheit e.V. (DTG), Gesellschaft f\u00fcr Tropenp\u00e4diatrie und Internationale Gesundheit e.V. (GTP): S1-Handlungsempfehlung: Diagnostik und Therapie der Loiasis (Afrikanischer Augenwurm) In: AWMF online. 2024 (in German)."},{"issue":"2","key":"1300_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106328","volume":"90","author":"C Thakker","year":"2025","unstructured":"Thakker C, Warrell C, Barrett J, Booth HL, Chiodini PL, Defres S, et al. UK guidelines for the investigation and management of eosinophilia in returning travellers and migrants. J Infect. 2025;90(2): 106328.","journal-title":"J Infect"},{"key":"1300_CR9","unstructured":"Loiasis (Loa loa infection). https:\/\/www.uptodate.com\/contents\/loiasis-loa-loa-infection?search=loiasis&source=search_result&selectedTitle=1~17&usage_type=def. Accessed 06 Feb 2024."},{"key":"1300_CR10","unstructured":"Loiasis (African Eye Worm) treatment and management. https:\/\/emedicine.medscape.com\/article\/2500105-treatment?form=fpf. Accessed 06 Feb 2024."},{"key":"1300_CR11","unstructured":"Loiasis. https:\/\/www.msdmanuals.com\/professional\/infectious-diseases\/nematodes-roundworms\/loiasis. Accessed 06 Feb 2024."},{"key":"1300_CR12","unstructured":"Clinical Treatment of Loiasis. https:\/\/www.cdc.gov\/filarial-worms\/hcp\/clinical-care\/loiasis.html. Accessed 27 Jan 2025."},{"issue":"4","key":"1300_CR13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0248-8663(01)00350-2","volume":"22","author":"E Caumes","year":"2001","unstructured":"Caumes E, Danis M. New indications of ivermectin. Rev Med Interne. 2001;22(4):379\u201384 (in French).","journal-title":"Rev Med Interne"},{"key":"1300_CR14","unstructured":"Loiasis (MSF Clinical guidelines\u2014diagnosis and treatment manual). https:\/\/medicalguidelines.msf.org\/en\/viewport\/CG\/english\/loiasis-16689895.html. Accessed 06 Feb 2024."},{"key":"1300_CR15","volume-title":"Antiparasitic treatment recommendations\u2014a practical guide to clinical parasitology","author":"A Neumayr","year":"2018","unstructured":"Neumayr A. Antiparasitic treatment recommendations\u2014a practical guide to clinical parasitology. 2nd ed. Allschwil: Tredition; 2018.","edition":"2"},{"key":"1300_CR16","volume-title":"Antibiotika-Therapie: Klinik und Praxis der antiinfekti\u00f6sen Behandlung; der\" neue Stille\"; mit 240 Tabellen","author":"H-R Brodt","year":"2013","unstructured":"Brodt H-R. Antibiotika-Therapie: Klinik und Praxis der antiinfekti\u00f6sen Behandlung; der\" neue Stille\"; mit 240 Tabellen. 12th ed. Stuttgart: Schattauer Verlag; 2013 (in German).","edition":"12"},{"issue":"11","key":"1300_CR17","doi-asserted-by":"publisher","first-page":"ofz417","DOI":"10.1093\/ofid\/ofz417","volume":"6","author":"KG Buell","year":"2019","unstructured":"Buell KG, Whittaker C, Chesnais CB, Jewell PD, Pion SDS, Walker M, et al. Atypical clinical manifestations of loiasis and their relevance for endemic populations. Open Forum Infect Dis. 2019;6(11):ofz417.","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"1300_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1179\/136485906X112194","volume":"100","author":"M Boussinesq","year":"2006","unstructured":"Boussinesq M. Loiasis. Ann Trop Med Parasitol. 2006;100(8):715\u201331.","journal-title":"Ann Trop Med Parasitol."},{"key":"1300_CR19","volume-title":"M\u00e9decine tropicale","author":"M Gentilini","year":"2012","unstructured":"Gentilini M, Caumes \u00c9, Danis M, Richard Lenoble D, B\u00e9gu\u00e9 P, Touze J-\u00c9, et al. M\u00e9decine tropicale. 6th ed. Paris: M\u00e9decine Sciences Publications Lavoisier; 2012 (in French).","edition":"6"},{"key":"1300_CR20","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511751660","volume-title":"Principles of medicine in Africa","author":"D Mabey","year":"2013","unstructured":"Mabey D, Parry E. Principles of medicine in Africa. Cambridge: Cambridge University Press; 2013."},{"issue":"3","key":"1300_CR21","doi-asserted-by":"publisher","first-page":"504","DOI":"10.4269\/ajtmh.22-0274","volume":"107","author":"E Pallara","year":"2022","unstructured":"Pallara E, Cotugno S, Guido G, De Vita E, Ricciardi A, Totaro V, et al. Loa loa in the vitreous cavity of the eye: a case report and state of art. Am J Trop Med Hyg. 2022;107(3):504\u201316.","journal-title":"Am J Trop Med Hyg"},{"key":"1300_CR22","volume-title":"Harrison\u2019s principles of internal medicine","author":"J Loscalzo","year":"2022","unstructured":"Loscalzo J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL. Harrison\u2019s principles of internal medicine. 21st ed. New York: McGraw Hill; 2022.","edition":"21"},{"key":"1300_CR23","unstructured":"Loiasis: African Eye Worm. https:\/\/web.stanford.edu\/group\/parasites\/ParaSites2009\/JosephCartwrigh. Accessed 19 Oct 2020."},{"key":"1300_CR24","volume-title":"Maladies infectieuses tropicales","author":"SPILF, CMIT, SFMTSI, SMV. ePILLY Trop [En ligne]","year":"2022","unstructured":"SPILF, CMIT, SFMTSI, SMV. ePILLY Trop [En ligne]. Maladies infectieuses tropicales. 3 ed. Paris: Editions Alin\u00e9a Plus; 2022 (in French).","edition":"3"},{"issue":"1424\u20133997","key":"1300_CR25","first-page":"13727","volume":"142","author":"J Utzinger","year":"2012","unstructured":"Utzinger J, Becker SL, Knopp S, Blum J, Neumayr AL, Keiser J, et al. Neglected tropical diseases: diagnosis, clinical management, treatment and control. Swiss Med Wkly. 2012;142(1424\u20133997):13727.","journal-title":"Swiss Med Wkly."},{"key":"1300_CR26","volume-title":"Tropenmedizin. Infektionskrankheiten","author":"CG Meyer","year":"2022","unstructured":"Meyer CG. Tropenmedizin. Infektionskrankheiten. 4 edn. Landsberg am Lech: ecomed Medizin; 2021 (in German).","edition":"4"},{"key":"1300_CR27","volume-title":"Oxford handbook of tropical medicine","author":"R Davidson","year":"2021","unstructured":"Davidson R, Brent AJ, Seale AC, Blumberg L. Oxford handbook of tropical medicine. 5th ed. Oxford: Oxford University Press; 2021.","edition":"5"},{"key":"1300_CR28","volume-title":"Tropenmedizin in Klinik und Praxis: mit Reise-und Migrationsmedizin","author":"A H\u00f6rauf","year":"2010","unstructured":"H\u00f6rauf A, Burchard GD. Filariosen und Drakunkulosen of chapter. In: L\u00f6scher T, Burchard GD, editors. Tropenmedizin in Klinik und Praxis: mit Reise-und Migrationsmedizin. Stuttgart: Georg Thieme Verlag; 2010 (In German)."},{"issue":"3","key":"1300_CR29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1708-8305.2012.00605.x","volume":"19","author":"M Boussinesq","year":"2012","unstructured":"Boussinesq M. Loiasis: new epidemiologic insights and proposed treatment strategy. J Travel Med. 2012;19(3):140\u20133.","journal-title":"J Travel Med"},{"key":"1300_CR30","volume-title":"Manson's tropical diseases","author":"J Farrar","year":"2024","unstructured":"Farrar J, Hotez PJ, Junghanss T, Kang G, Lalloo D, White NJ, et al. Manson\u2019s tropical diseases. 24th ed. Amsterdam: Elsevier; 2024.","edition":"24"},{"issue":"3","key":"1300_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3347\/kjp.2021.59.3.189","volume":"59","author":"JY Chai","year":"2021","unstructured":"Chai JY, Jung BK, Hong SJ. Albendazole and mebendazole as anti-parasitic and anti-cancer agents: an update. Korean J Parasitol. 2021;59(3):189\u2013225.","journal-title":"Korean J Parasitol"},{"issue":"4","key":"1300_CR32","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/jca.21620","volume":"33","author":"AP Norgan","year":"2018","unstructured":"Norgan AP, Juskewitch JE, Pritt BS, Winters JL. The use of cytapheresis in the treatment of infectious diseases. J Clin Apher. 2018;33(4):529\u201337.","journal-title":"J Clin Apher"},{"key":"1300_CR33","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 HAS. Actualisation de la nomenclature des actes de biologie m\u00e9dicale pour le diagnostic et le suivi des filarioses. In: Saint-Denis La Plaine; 2018 (in French)."},{"issue":"4","key":"1300_CR34","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.pt.2017.12.003","volume":"34","author":"C Whittaker","year":"2018","unstructured":"Whittaker C, Walker M, Pion SDS, Chesnais CB, Boussinesq M, Basanez MG. The population biology and transmission dynamics of Loa loa. Trends Parasitol. 2018;34(4):335\u201350.","journal-title":"Trends Parasitol"},{"key":"1300_CR35","volume-title":"Parasitic diseases, parasites without borders","author":"D Despommier","year":"2019","unstructured":"Despommier D, Griffin D, Gwadz R, Hotez P, Knirsch C. Parasitic diseases, parasites without borders. 7th ed. New York: Inc. NY; 2019.","edition":"7"},{"key":"1300_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-48678-8","volume-title":"Medizinische Mikrobiologie und Infektiologie","author":"S Suerbaum","year":"2016","unstructured":"Suerbaum S, Burchard GD, Kaufmann SH, Schulz TF. Medizinische Mikrobiologie und Infektiologie. Berlin: Springer-Verlag; 2016 (in German)."},{"issue":"11","key":"1300_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e11367","volume":"8","author":"GA Asare","year":"2022","unstructured":"Asare GA, Fiador K, Tsede E, John L, Srofenyoh EK. Analysis of first apheresis services in Ghana-greater Accra regional hospital. Heliyon. 2022;8(11): e11367.","journal-title":"Heliyon"},{"issue":"4","key":"1300_CR38","doi-asserted-by":"publisher","first-page":"914","DOI":"10.4269\/ajtmh.18-0693","volume":"100","author":"F Gobbi","year":"2019","unstructured":"Gobbi F, Tamarozzi F, Buonfrate D, Rodari P, Tais S, Bisoffi Z. Laboratory parameters after treatment for Loa loa and Mansonella perstans: the experience of a single referral center for tropical diseases in a non-endemic area. Am J Trop Med Hyg. 2019;100(4):914\u201320.","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"1300_CR39","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.tmaid.2013.08.005","volume":"11","author":"N Gantois","year":"2013","unstructured":"Gantois N, Rapp C, Gautret P, Ficko C, Savini H, Larreche S, et al. Imported loiasis in France: a retrospective analysis of 47 cases. Travel Med Infect Dis. 2013;11(6):366\u201373.","journal-title":"Travel Med Infect Dis"},{"issue":"9","key":"1300_CR40","doi-asserted-by":"publisher","first-page":"e649","DOI":"10.1016\/j.ijid.2012.05.1023","volume":"16","author":"S Antinori","year":"2012","unstructured":"Antinori S, Schifanella L, Million M, Galimberti L, Ferraris L, Mandia L, et al. Imported Loa loa filariasis: three cases and a review of cases reported in non-endemic countries in the past 25 years. Int J Infect Dis. 2012;16(9):e649-662.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"1300_CR41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12936-023-04454-0","volume":"22","author":"M Chibi","year":"2023","unstructured":"Chibi M, Wasswa W, Ngongoni C, Baba E, Kalu A. Leveraging innovation technologies to respond to malaria: a systematized literature review of emerging technologies. Malar J. 2023;22(1):40.","journal-title":"Malar J"}],"container-title":["Infectious Diseases of Poverty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-025-01300-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40249-025-01300-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-025-01300-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T03:44:25Z","timestamp":1746589465000},"score":1,"resource":{"primary":{"URL":"https:\/\/idpjournal.biomedcentral.com\/articles\/10.1186\/s40249-025-01300-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1300"],"URL":"https:\/\/doi.org\/10.1186\/s40249-025-01300-0","relation":{},"ISSN":["2049-9957"],"issn-type":[{"value":"2049-9957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"18 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent from Franck Aurelien Ekoka Mbassi obtained for graphical abstract image.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}